U.S. Tobacco Stock News

NasdaqGS:FTDR
NasdaqGS:FTDRConsumer Services

Frontdoor (FTDR) Valuation In Focus After New Global Tariff Uncertainty

Tariff shock puts Frontdoor under the spotlight The Trump administration’s new 15% global tariff, imposed for up to 150 days, has injected fresh policy risk into trade exposed names. Frontdoor (FTDR) slipped 3.9% as investors reassess that uncertainty. See our latest analysis for Frontdoor. Beyond the tariff shock, Frontdoor’s share price has been choppy, with a 1 day share price return of 1.33% contrasting with a 30 day share price return decline of 4.83%. The 3 year total shareholder return...
NYSE:ENVA
NYSE:ENVAConsumer Finance

Is It Time To Reassess Enova International (ENVA) After Its Strong Multi‑Year Rally?

If you are wondering whether Enova International's current share price fairly reflects its underlying worth, you are not alone. That is exactly what this valuation focused review is set up to unpack for you. The stock last closed at US$144.43, with returns of 41.0% over 1 year, 190.1% over 3 years and 351.3% over 5 years, even as the share price has seen a 3.1% decline over 7 days, an 8.9% decline over 30 days and a 10.8% decline year to date. Recent attention on Enova International has been...
NasdaqGS:MKSI
NasdaqGS:MKSISemiconductor

How AI-Linked Q4 Beat And 2026 Outlook At MKS (MKSI) Has Changed Its Investment Story

MKS Inc. has already reported fourth-quarter 2025 revenue of US$1,033 million and net income of US$108 million, alongside full-year revenue of US$3.93 billion and net income of US$295 million, with higher earnings per share from continuing operations versus the prior year. The company linked this improvement to expanding Electronics & Packaging demand tied to AI-driven semiconductor capacity builds and issued first-quarter 2026 revenue guidance of about US$1,040 million, plus or minus US$40...
NYSE:NX
NYSE:NXBuilding

How Margin Deterioration Amid Revenue Growth At Quanex Building Products (NX) Has Changed Its Investment Story

Over the past few years, Quanex Building Products has experienced a significant drop in operating margin, earnings per share, and return on invested capital despite continuing to grow its revenue base. This combination of rising costs and weaker profitability on a per‑share and invested‑capital basis points to mounting operational pressures and fewer attractive growth opportunities within the business. Next, we’ll examine how this sustained margin deterioration challenges Quanex’s earlier...
NYSE:KFY
NYSE:KFYProfessional Services

How New 15% Global Tariffs Under the Trade Act of 1974 At Korn Ferry (KFY) Has Changed Its Investment Story

The Trump administration recently imposed a 15% global tariff for up to 150 days under the Trade Act of 1974, reviving trade policy uncertainty for companies with international exposure such as Korn Ferry. For a consulting firm reliant on cross-border corporate activity, this renewed tariff risk raises questions about client spending plans and the pace of large transformation projects. We’ll now examine how the new 15% global tariffs and heightened trade uncertainty could affect Korn Ferry’s...
NYSE:HEI
NYSE:HEIAerospace & Defense

Did Strong Q1 2026 Results and EthosEnergy Deal Just Shift HEICO's (HEI) Investment Narrative?

HEICO Corporation has released its first-quarter 2026 results, reporting sales of US$1,178.58 million and net income of US$190.19 million, with both basic and diluted EPS from continuing operations increasing compared with the same period last year. Alongside this earnings release, HEICO’s recent acquisition of EthosEnergy Accessories and Components through its Wencor Group subsidiary highlights how management is expanding its position in engine parts repair for both aviation and industrial...
NasdaqGS:NXPI
NasdaqGS:NXPISemiconductor

Assessing NXP Semiconductors (NXPI) Valuation After Recent Share Price Moves And Undervaluation Signals

What recent performance data suggests for NXP Semiconductors (NXPI) NXP Semiconductors (NXPI) has attracted fresh attention after recent share price moves, with a last close of US$235.07 and returns of 0.2% over the past day and a 0.9% decline over the past week. Over the past month the stock shows a 1.7% gain, while the past 3 months point to a 21.3% return and 4.4% over the past year, giving investors several different holding periods to compare. See our latest analysis for NXP...
NYSE:ACI
NYSE:ACIConsumer Retailing

Is Albertsons Companies (ACI) Pricing Reflect The Kroger Merger Uncertainty And Recent Valuation Signals

If you are wondering whether Albertsons Companies' current share price really reflects its underlying value, you are not alone. This article walks through the key signals that matter for you as a shareholder or potential investor. The stock most recently closed at US$17.70, with returns of 2.8% over the last 30 days, 2.3% year to date, and an 11.8% decline over the past year, which may hint at changing expectations around both opportunity and risk. Recent news coverage has focused on...
NYSE:SON
NYSE:SONPackaging

A Look At Sonoco (SON) Valuation After Strong Earnings Recovery And Fresh 2026 Guidance

Sonoco Products (SON) has quickly drawn fresh attention after reporting fourth quarter and full year 2025 results that shifted from a prior year loss to profitability, alongside issuing revenue guidance for 2026. See our latest analysis for Sonoco Products. The latest earnings swing back to profit and fresh 2026 revenue guidance have arrived alongside strong momentum, with a 30 day share price return of 14.1% and a 1 year total shareholder return of 24.71% suggesting improving sentiment...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Is Up 10.2% After FDA Accepts Full Review Of Its mRNA Flu Vaccine

In February 2026, Moderna’s mRNA-based seasonal flu vaccine application, initially rejected by the U.S. Food and Drug Administration over trial design concerns, was later accepted for full review with a decision expected by August 5, 2026. This reversal gives Moderna clearer regulatory visibility on its flu program at a time when the company is reporting lower revenues and continued net losses from 2025. We’ll now examine how the FDA’s decision to review Moderna’s mRNA flu vaccine could...
NasdaqGM:INOD
NasdaqGM:INODProfessional Services

Assessing Innodata (INOD) Valuation After Palantir And Missile Defense Agency Wins

Why Palantir and Missile Defense Agency Wins Matter for Innodata Innodata (INOD) is back on investors’ radar after being selected by Palantir to supply training data and generative AI workflow support, along with a separate contract with the Missile Defense Agency for future missile defense research and prototyping work. See our latest analysis for Innodata. These Palantir and Missile Defense Agency wins arrive after a choppy period, with the latest share price at US$46.19 and a 7 day share...
NasdaqGS:SLM
NasdaqGS:SLMConsumer Finance

Assessing SLM’s (SLM) Valuation After Recent Share Price Weakness And Perceived 35.5% Discount

What SLM’s recent performance means for investors SLM (SLM) has drawn investor attention after a stretch of weaker share performance, with the stock down over the past month and past 3 months. This has prompted fresh questions about how its valuation lines up with fundamentals. See our latest analysis for SLM. At a share price of US$20.40, SLM’s recent 7 day and 30 day share price returns of 14.64% and 25.49% declines respectively extend a weaker trend, even though its 3 year total...
NasdaqGS:MAR
NasdaqGS:MARHospitality

Marriott’s New US$1.44 Billion Bond Deal and Dividend Policy Might Change The Case For Investing In MAR

In February 2026, Marriott International completed two fixed‑income offerings totaling about US$1.44 billion, issuing callable senior unsecured notes due 2033 and 2038, with major banks including J.P. Morgan, BofA Securities, Wells Fargo, HSBC, Scotia Capital, Truist and U.S. Bancorp acting as co‑lead underwriters. Together with a recently affirmed quarterly dividend of US$0.67 per share, these bond issues highlight Marriott’s focus on maintaining liquidity while continuing to fund its...
NYSE:BVN
NYSE:BVNMetals and Mining

Compañía de Minas Buenaventura (BVN) Is Up 5.9% After Issuing 2026 Multi‑Metal Production Guidance

Compañía de Minas Buenaventura S.A.A. recently reported its fourth quarter and full-year 2025 operating and sales results, detailing production of gold, silver, lead, zinc and copper alongside corresponding metals sold. At the same time, the company issued 2026 production guidance across all five metals, giving investors a clearer view of expected output levels and operational planning. Next, we’ll examine how the newly issued 2026 multi-metal production guidance shapes Buenaventura’s...
NYSE:ITW
NYSE:ITWMachinery

Illinois Tool Works Credit Facility Refreshes Liquidity As Valuation Runs Rich

Illinois Tool Works (NYSE:ITW) has entered into a new US$3.0b five year revolving credit facility. The agreement replaces the company’s previous revolving credit facility more than a year before its scheduled expiry. The facility includes multi currency and rate options and can be increased to up to US$5b, subject to conditions. Illinois Tool Works, a diversified industrial manufacturer serving multiple end markets, now has a refreshed liquidity backstop that can support its ongoing...
NYSE:FICO
NYSE:FICOSoftware

Should FICO’s New US$1.50 Billion Buyback and Mortgage Tools Shift Its Investment Narrative (FICO)?

In February 2026, Fair Isaac Corporation (FICO) completed a US$1.00 billion share repurchase under its June 2025 authorization, closed that plan, and the Board approved a new program to buy back up to US$1.50 billion of its common stock, while myFICO launched a Mortgage Score Simulator to help consumers model how credit actions may affect mortgage readiness. Alongside a fresh buyback authorization, FICO is extending its influence in mortgage credit through consumer tools and expanded...
NasdaqCM:NAGE
NasdaqCM:NAGEPersonal Products

Assessing Niagen Bioscience (NAGE) Valuation After Recent Share Price Volatility

What the recent performance says about Niagen Bioscience Niagen Bioscience (NAGE) has been on many watchlists after recent share price swings, including a 4.3% move over the past day and a 6.6% gain over the past week. Those short term moves sit against a weaker month and past 3 months, with returns of a 14.4% decline and a 22.6% decline, while the 1 year total return shows a smaller 5.8% decline. See our latest analysis for Niagen Bioscience. That recent 1 day and 7 day share price strength...
NYSE:AME
NYSE:AMEElectrical

How AMETEK’s 10% Dividend Hike Shapes Its Capital Allocation Story for AME Investors

In February 2026, AMETEK, Inc. announced that its Board of Directors approved a 10% increase in the quarterly cash dividend on common stock to US$0.34 per share from US$0.31, with the first-quarter dividend paid on March 31, 2026 to shareholders of record as of March 16, 2026, lifting the indicated annual rate to US$1.36 per share. This higher dividend payout underlines the company’s willingness to return more cash to shareholders, which many investors interpret as a sign of underlying...
NYSE:HPQ
NYSE:HPQTech

HPQ Q1 2026 Margin Compression Reinforces Bear Narratives On Profitability

HP (HPQ) has opened Q1 2026 with revenue of US$14.4b and basic EPS of US$0.59, putting fresh numbers on the table for investors tracking how the story is evolving. The company has seen quarterly revenue move from US$14.1b in Q4 2024 to US$13.5b in Q1 2025 and US$14.4b in Q1 2026, while basic EPS has shifted from US$0.94 to US$0.60 and now US$0.59, setting a clear earnings run rate for the latest quarter. With these results in hand, the focus now turns to what they signal about HP's margin...
NasdaqGS:EXE
NasdaqGS:EXEOil and Gas

Is It Too Late To Consider Expand Energy (EXE) After Its Recent Share Price Strength

If you are trying to figure out whether Expand Energy is still reasonably priced after its run so far, this article will walk you through what the current share price might mean for you. The stock most recently closed at US$106.05, with returns of 6.6% over 7 days, a 5.6% decline over 30 days, a 3.4% decline year to date, 6.8% over 1 year, 44.7% over 3 years and 182.2% over 5 years. Recent company specific news has kept interest in Expand Energy alive, giving investors more information to...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Why Royal Gold (RGLD) Is Up 5.8% After Mixed Q4 Results And Major Portfolio Expansion

Royal Gold, Inc. reported its fourth-quarter and full-year 2025 results, with quarterly sales rising to US$373.1 million while net income eased to US$93.61 million, and full-year sales and net income reaching US$1.02 billion and US$466.28 million respectively. Alongside these results, Royal Gold has expanded and diversified its portfolio through the Sandstorm-Horizon transactions, doubling its visible growth pipeline and reshaping its mix of producing and development assets. We’ll now...
NasdaqGS:WTW
NasdaqGS:WTWInsurance

Assessing Willis Towers Watson (WTW) Valuation After Mixed Share Performance And Margin Optimism

Event context and recent share performance Willis Towers Watson (WTW) has drawn investor attention after a mixed stretch, with the share price showing a 1.9% gain over the past day but negative returns over the past week, month, past 3 months and year to date. See our latest analysis for Willis Towers Watson. The recent 1 day share price return of 1.9% to US$296.84 comes after a weaker patch, with the 30 day share price return of 7.8% and year to date share price return of 9% both in decline...
NasdaqGS:WTFC
NasdaqGS:WTFCBanks

Did Record Q4 Earnings and Loan Growth Just Shift Wintrust Financial's (WTFC) Investment Narrative?

Wintrust Financial recently reported fourth-quarter results showing an 11% year-on-year rise in revenue to US$715.6 million, alongside record net income and net interest income driven by broad-based loan and deposit growth. Management’s emphasis on strong balance sheet expansion and a 19% improvement in net income underscores how core banking activities are supporting the company’s operating momentum. With these record earnings and balance sheet gains, we’ll now examine how Wintrust’s...
NYSE:FHN
NYSE:FHNBanks

Is First Horizon’s Earnings Beat And 8.1% Revenue Growth Altering The Investment Case For FHN?

Earlier this week, First Horizon reported an 8.1% year-on-year increase in revenue and a strong beat on both overall revenue and net interest income estimates, following a generally satisfactory quarter for regional banks. The earnings surprise highlights how First Horizon’s core lending and interest income engine is currently outperforming analyst expectations, setting it apart within the regional banking group. We’ll now examine how First Horizon’s stronger-than-expected revenue and net...